COVID-19 Claims In Instagram By OTC IV Provider
Executive Summary
After challenging claims made in Instagram post and advised business offering walk-in and by-appointment services at multiple NYC locations, NAD referred its questions to regulators after the firm failed to provide substantiation.
You may also be interested in...
US Hospitals’ COVID-19 Treatment Protocols Aren’t Prescriptions To Make Vitamin C Ad Claims
Marketer of Billy’s Infinity-C supplement line discontinues social media post that COVID-19 patients in hospitals are receiving high doses of vitamin C. BBB National Programs division says the post implies consumers can prevent contracting the virus through vitamin C use.
US COVID-19 Fraud: Licorice Promoted As Treatment, Unapproved Tests Offered OTC
FDA and FTC continue adding to total each has made during novel coronavirus pandemic. FTC's latest include peroxide gel and licorice as treatments; FDA’s emphasizes in warnings that three businesses' tests were not approved for OTC sales or for home use.
Jurors' Answers In FTC's Prevagen Complaint Might Burst A Memory Bubble For Health Claims
“No” answers in New York federal court on whether all but two of Prevagen claims were “materially misleading” could put a fork in the road of a long dispute between FTC and supplement product manufacturers and marketers.